Alumis ALMS
NASDAQ ALMS
$7.30 +0.01 (+0.21%)
As of: Sep 30, 2026 · 10:25 AM EDT

Alumis (ALMS) EBITDA Margin (2025)

Updated

Alumis (ALMS) posted EBITDA Margin of -4954.80% for Q4 2025, up 581.31 percentage points from the prior quarter.

Analysis

Alumis (ALMS) EBITDA Margin (2025) Analysis & Trends

For FY2025, Alumis' EBITDA Margin came in at -1872.38%.

  • Quarterly EBITDA Margin has run from a low of -5536.11% in Q3 2025 to a high of -578.65% in Q1 2025 over five years.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -5536.11% (Q3 2025), -5238.90% (Q2 2025) and -578.65% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Alumis 891.03 Mn -783.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,954.80%
Sep 30, 2025 -5,536.11%
Jun 30, 2025 -5,238.90%
Mar 31, 2025 -578.65%
API Access

Alumis EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY